{"id":13485,"date":"2007-01-05T12:32:40","date_gmt":"2007-01-05T11:32:40","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=13485"},"modified":"2022-09-14T13:11:50","modified_gmt":"2022-09-14T11:11:50","slug":"barbieri-m-drummond-m-puig-junoy-j-casado-ma-ballina-fj-blasco-p-poveda-jl","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/barbieri-m-drummond-m-puig-junoy-j-casado-ma-ballina-fj-blasco-p-poveda-jl\/","title":{"rendered":"Barbieri M, Drummond M, Puig-Junoy J, Casado MA, Ballina FJ, Blasco P, Poveda JL"},"content":{"rendered":"<div class=\"miniatura_foto\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-13486 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/07\/expert_review_of_pharmacoeconomic_and_outcomes_research.jpg\" alt=\"\" width=\"90\" height=\"120\" \/><\/div>\n<p><strong>Barbieri M, Drummond M, Puig-Junoy J, Casado MA, Ballina FJ, Blasco P, Poveda JL<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h6 style=\"text-align: justify;\">A critical appraisal of pharmacoeconomic studies comparing TNFa antagonists for the treatment of rheumatoid arthritis<\/h6>\n<h6 style=\"text-align: justify;\"><strong>Exp Rev Pharmacoeconomic Outcomes Res. 2007;7:613-26<\/strong><\/h6>\n<div class=\"col80p\">\n<p style=\"text-align: justify;\"><a href=\"http:\/\/www.expert-reviews.com\/doi\/abs\/10.1586\/14737167.7.6.613?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed\" target=\"_blank\" rel=\"noopener\">M\u00c1S INFORMACI\u00d3N<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Barbieri M, Drummond M, Puig-Junoy J, Casado MA, Ballina FJ, Blasco P, Poveda JL &nbsp; &nbsp; A critical appraisal of pharmacoeconomic studies comparing TNFa antagonists for the treatment of rheumatoid arthritis Exp Rev Pharmacoeconomic Outcomes Res. 2007;7:613-26 M\u00c1S INFORMACI\u00d3N<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[919,941,327],"tags":[],"class_list":["post-13485","post","type-post","status-publish","format-quote","hentry","category-enfermedades-autoinmunes","category-revisiones-y-comparaciones-indirectas-tipo-de-proyecto","category-expert-review-of-pharmacoeconomic-and-outcomes-research","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13485"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=13485"}],"version-history":[{"count":2,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13485\/revisions"}],"predecessor-version":[{"id":22422,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13485\/revisions\/22422"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=13485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=13485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=13485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}